New research indicates that individuals who come off new weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end traditional diet and exercise plans.
Research printed in a leading health publication shows that while obese people frequently drop about a fifth of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month once they quit.
"People buying such medications should be cognizant of the danger of quick weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.
This pace of regain means a reversion to original mass within about 18 months.
Analyzing Therapies
The analysis, which looked at dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with conventional dieting.
The team emphasize that people who lose weight through lifestyle changes alone generally have a more gradual creep back—around 100 grams monthly—once they finish.
The Reason for the Rapid Rebound
Nutrition scientists suggest the mode of action of the injections explains the accelerated weight return.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Condition?
Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, given the high risk of relapse, the treatment is often long-term.
This perspective is echoed by drug manufacturers, who say that the findings "highlight the chronic character of excess weight," comparing it to managing conditions like diabetes.
Patient Testimonies
People who have stopped the medication describe a sudden resurgence of hunger.
"I experienced something that goes on and I was suddenly extremely hungry," recalled one woman.
This difficulty is worsened if users have not adopted permanent dietary or behavioural changes during therapy.
Growing Adoption
Figures indicate that millions of adults in the UK have tried these injections in the past year, with demand being substantial.
- Use is more common among women than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Ultimately, experts stress that while the jabs are powerful agents for shedding pounds, they are not a magic solution and maintained weight loss relies on combined behavioural support.
